Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Form 8.5 (EPT/RI) - Smart Metering Systems plc
-
AKVA group ASA: Invitation – presentation of the Q4 2023 financial results
-
Hydrogen storage: H2V and Vallourec sign partnership agreement
-
Trial mining license at Coringa renewed for a further three years
-
Norsk Hydro: Status share buyback program
-
LifeArc makes multi-million pound investment to support drug discovery in sub-Saharan Africa
-
Interim Results: 1 May 2023 – 31 October 2023
-
Lleida.net Strengthens Collaboration with Ibercaja in the Management of Debit Balance Notifications
-
Riber: 2023 revenues up +41% to €39.2m
-
Fingerprint Cards AB (publ): Increase in number of B shares and votes
-
Change in Arco Vara’s profit forecast
-
HYFI 2024 Singapore: Beyond Boundaries: Web3, AI, and the Future of Technology
-
Novo Nordisk's sales increased by 31% in Danish kroner and by 36% at constant exchange rates to DKK 232.3 billion in 2023
-
Elanders AB: Year-end Report 2023
-
BGHL (GBP): NAV(s)
-
BGHL (EUR): NAV(s)
-
-
Implementation of share buy-back programme
-
Nicox Receives Confirmation of 5-year Patent Term Extension of U.S. Patent for Latanoprostene Bunod, Commercialized as VYZULTA®
-
Ringkjøbing Landbobank’s annual report for 2023
-
Net asset value of the EfTEN United Property Fund as of 31.12.2023
-
Net asset value of the EfTEN United Property Fund as of 31.12.2023
-
Addex Enters into At-The-Market ADS Offering Agreement with H.C. Wainwright & Co. LLC.
-
Novartis delivers strong full year performance, 10% net sales and 18% core operating income growth (cc¹), with margin expansion. Continuing innovation momentum with multiple positive Ph3 readouts
-
Addex Enters into At-The-Market ADS Offering Agreement with H.C. Wainwright & Co. LLC.
-
Start of Day Message
-
Borregaard ASA: EBITDA1 of NOK 327 million in the 4th quarter
-
Sandoz launches first and only biosimilar for multiple sclerosis, Tyruko® (natalizumab), in Germany
-
Geneva Court Grants Temporary Moratorium to ObsEva
-
Corbion management presents strategic development update on ‘Advance 2025’
-
ANeuroTech publishes Phase IIIa data for ANT-01, an adjunctive anti-depression drug, in Personalized Medicine in Psychiatry
-
Publication of a transparency notification
-
Borregaard ASA: Key information related to the cash dividend
-
Borregaard ASA: The Board of Directors’ dividend proposal to Borregaard’s Annual General Meeting
-
Digital 2024: Global social media users pass 5 billion milestone
-
Vaxcyte Announces Pricing of $750 Million Public Offering
-
Immunocore Prices Upsized Convertible Senior Notes Offering
-
BOEING ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against The Boeing Company and Encourages Investors to Contact the Firm
-
AMAZON ALERT: Bragar Eagel & Squire, P.C. is Investigating Amazon.com, Inc. on Behalf of Amazon Options Traders and Encourages Investors to Contact the Firm
-
BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting
-
BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting
-
23andMe Launches Month-Long Initiative to Amplify ARRAY’s “Seat16” Program for Acclaimed Film ORIGIN by Ava DuVernay
-
Check Point Software Unveils Infinity AI Copilot: Transforming Cyber security with Intelligent GenAI Automation and Support
-
Appendix 4C Quarterly Activity Report for Quarter Ended December 31, 2023
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against GrafTech, and Instacart and Encourages Investors to Contact the Firm
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Blue Ridge Bankshares, Lovesac, Future FinTech, and AlloVir and Encourages Investors to Contact the Fir
-
Bragar Eagel & Squire, P.C. Is Investigating Brooge, Equity, and HUT and Encourages Investors to Contact the Firm
-
BTI INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that British American Tobacco p.l.c. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
ROSEN, A RANKED AND LEADING FIRM, Encourages VNET Group, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – VNET
-
ROSEN, SKILLED INVESTOR COUNSEL, Encourages ON Semiconductor Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – ON
